Zhenwei Fang

440 total citations
14 papers, 328 citations indexed

About

Zhenwei Fang is a scholar working on Molecular Biology, Surgery and Neurology. According to data from OpenAlex, Zhenwei Fang has authored 14 papers receiving a total of 328 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 3 papers in Surgery and 3 papers in Neurology. Recurrent topics in Zhenwei Fang's work include Antiplatelet Therapy and Cardiovascular Diseases (3 papers), Intracerebral and Subarachnoid Hemorrhage Research (3 papers) and Diabetes Treatment and Management (3 papers). Zhenwei Fang is often cited by papers focused on Antiplatelet Therapy and Cardiovascular Diseases (3 papers), Intracerebral and Subarachnoid Hemorrhage Research (3 papers) and Diabetes Treatment and Management (3 papers). Zhenwei Fang collaborates with scholars based in China and United States. Zhenwei Fang's co-authors include Tiansheng Wang, Huilin Tang, Su Shen, Yue Dong, Dandan Li, Suodi Zhai, Wei Cui, Yiqing Song, Lin Yang and Jialun Han and has published in prestigious journals such as SHILAP Revista de lepidopterología, The American Journal of Cardiology and Neuroreport.

In The Last Decade

Zhenwei Fang

14 papers receiving 321 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Zhenwei Fang China	6	226	111	97	51	44	14	328
Shinji Kamei Japan	11	191 0.8×	105 0.9×	90 0.9×	30 0.6×	32 0.7×	44	356
Evangelia Tzeravini Greece	6	192 0.8×	85 0.8×	94 1.0×	36 0.7×	32 0.7×	14	299
Yshai Yavin United States	10	262 1.2×	98 0.9×	98 1.0×	69 1.4×	69 1.6×	20	351
Aaron Y. Kluger United States	9	231 1.0×	114 1.0×	107 1.1×	98 1.9×	63 1.4×	17	364
Jimmy Ren United States	4	374 1.7×	173 1.6×	143 1.5×	116 2.3×	44 1.0×	8	439
Steven Sambevski United States	5	336 1.5×	134 1.2×	168 1.7×	118 2.3×	90 2.0×	9	438
Lubin Xu China	7	225 1.0×	108 1.0×	114 1.2×	44 0.9×	81 1.8×	17	399
Taha Sen Netherlands	8	203 0.9×	101 0.9×	73 0.8×	27 0.5×	37 0.8×	12	301
Ana Pokrajac United Kingdom	10	352 1.6×	104 0.9×	85 0.9×	47 0.9×	14 0.3×	17	432
M. France United Kingdom	9	108 0.5×	143 1.3×	81 0.8×	41 0.8×	31 0.7×	16	345

Countries citing papers authored by Zhenwei Fang

Since Specialization

Citations

This map shows the geographic impact of Zhenwei Fang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhenwei Fang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhenwei Fang more than expected).

Fields of papers citing papers by Zhenwei Fang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhenwei Fang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhenwei Fang. The network helps show where Zhenwei Fang may publish in the future.

Co-authorship network of co-authors of Zhenwei Fang

This figure shows the co-authorship network connecting the top 25 collaborators of Zhenwei Fang. A scholar is included among the top collaborators of Zhenwei Fang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhenwei Fang. Zhenwei Fang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Wu, Xinghan, Tiejun Zhang, Yining Chen, et al.. (2024). Perspective insights into versatile hydrogels for stroke: From molecular mechanisms to functional applications. Biomedicine & Pharmacotherapy. 173. 116309–116309. 5 indexed citations

Fang, Zhenwei, et al.. (2024). Efficacy and Safety of Oral Semaglutide in the Treatment of Type 2 Diabetes: A Meta‐Analysis. The Journal of Clinical Pharmacology. 64(10). 1312–1325. 4 indexed citations

Bai, Yang, Ying Zhang, Chenyu Zhang, et al.. (2024). Febuxostat attenuates secondary brain injury caused by cerebral hemorrhage through inhibiting inflammatory pathways.. SHILAP Revista de lepidopterología. 27(6). 740–746. 4 indexed citations

Bai, Yang, Bin Wu, Zhenwei Fang, et al.. (2023). Cardiovascular Safety Evaluation of Febuxostat and Allopurinol: Findings from the FDA Adverse Event Reporting System. Journal of Clinical Medicine. 12(18). 6089–6089. 6 indexed citations

Zhang, Chenyu, Ying Zhang, Qi Wang, et al.. (2023). Febuxostat, a xanthine oxidase inhibitor, regulated long noncoding RNAs and protected the brain after intracerebral hemorrhage. Neuroreport. 34(14). 703–712. 2 indexed citations

Zhang, Chenyu, Ying Zhang, Qi Wang, et al.. (2023). Long non-coding RNAs in intracerebral hemorrhage. Frontiers in Molecular Neuroscience. 16. 1119275–1119275. 3 indexed citations

Han, Jialun, et al.. (2022). Ticagrelor vs. Clopidogrel in Older Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: Insights From a Real-World Registry. Frontiers in Cardiovascular Medicine. 9. 859962–859962. 5 indexed citations

Zhang, Yi, Jialun Han, Ru Zhang, et al.. (2021). Impact of Implementing CYP2C19 Genotype-Guided Antiplatelet Therapy on P2Y12 Inhibitor Selection and Clinical Outcomes in Acute Coronary Syndrome Patients After Percutaneous Coronary Intervention: A Real-World Study in China. Frontiers in Pharmacology. 11. 582929–582929. 21 indexed citations

Zhang, Yi, Jialun Han, Peng Wen-xing, et al.. (2021). Convallatoxin Promotes M2 Macrophage Polarization to Attenuate Atherosclerosis Through PPARγ-Integrin αvβ5 Signaling Pathway. Drug Design Development and Therapy. Volume 15. 803–812. 24 indexed citations

10.

Zhang, Yi, Ru Zhang, Jialun Han, et al.. (2021). Personalized Antiplatelet Therapy Based on CYP2C19 Genotypes in Chinese ACS Patients Undergoing PCI: A Randomized Controlled Trial. Frontiers in Cardiovascular Medicine. 8. 676954–676954. 6 indexed citations

11.

Zhang, Yi, Jialun Han, Peng Wen-xing, et al.. (2021). Tryptanthrin Regulates Vascular Smooth Muscle Cell Phenotypic Switching in Atherosclerosis by AMP-Activated Protein Kinase/Acetyl-CoA Carboxylase Signaling Pathway. Journal of Cardiovascular Pharmacology. 77(5). 642–649. 3 indexed citations

12.

Tang, Huilin, Zhenwei Fang, Tiansheng Wang, et al.. (2016). Meta-Analysis of Effects of Sodium-Glucose Cotransporter 2 Inhibitors on Cardiovascular Outcomes and All-Cause Mortality Among Patients With Type 2 Diabetes Mellitus. The American Journal of Cardiology. 118(11). 1774–1780. 60 indexed citations

13.

Li, Dandan, Tiansheng Wang, Su Shen, et al.. (2016). Urinary tract and genital infections in patients with type 2 diabetes treated with sodium‐glucose co‐transporter 2 inhibitors: A meta‐analysis of randomized controlled trials. Diabetes Obesity and Metabolism. 19(3). 348–355. 184 indexed citations

14.

Fang, Zhenwei, et al.. (2010). [A meta-analysis of aprepitant for prevention of chemotherapy-induced nausea and vomiting].. PubMed. 42(6). 756–63. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact